Adrien Herlédan
Inserm(FR)Université de Lille(FR)Institut Pasteur de Lille(FR)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Biochemical and Molecular Research, Tuberculosis Research and Epidemiology, Advanced Biosensing Techniques and Applications, Computational Drug Discovery Methods
Most-Cited Works
- → Receptor-Interacting Protein 140 Differentially Regulates Estrogen Receptor-Related Receptor Transactivation Depending on Target Genes(2006)106 cited
- → Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice(2015)95 cited
- → Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis(2009)81 cited
- → Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism(2016)78 cited
- → BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation(2019)74 cited
- → Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps(2022)62 cited